Viral Hepatitis Vaccine

AIM Action is a professional manufacturer and supplier of viral hepatitis vaccines. This vaccine is used to prevent viral hepatitis caused by infection with specific hepatotropic viruses.

Status of Prevention of Viral Hepatitis and the Role of Vaccines

Viral hepatitis is a major global public health challenge, with different types, routes of transmission and prevention strategies.

Comparison of main types of viral hepatitis

The Role of AIM Action: Focusing on the Most Transmissible Hepatitis A

Hepatitis A virus spreads through daily contact with contaminated food and water, making it highly prone to outbreaks in crowded areas. Therefore, immunization against hepatitis A holds immense public health significance. AIM Action's inactivated hepatitis A vaccine is the core product addressing this need. By establishing active immunity, it creates a specific defense against the hepatitis A virus, representing the most cost-effective and effective medical solution for preventing viral hepatitis (type A).

Components and Description

The inactivated hepatitis A vaccine is a preparation made from hepatitis A virus (HAV) LV8 strain grown in human diploid cell KMB17 strain. After cultivation and harvest, the virus suspension Is purified and inactivated. A quantity of aluminum adjuvant is added to make the vaccine. It is a slightly milky-white suspension. Stratified precipitate may form which can be dispersed by shaking.

Active constituent: Inactivated hepatitis A virus.

Excipients: Aluminum hydroxide, 2-phenoxyethanol, glycine,sodium hydrogen sulfite, sodium hydroxide, and phosphate buffered saline (PBS).

Eligibles

For Pediatric Use：Hepatitis A-susceptible individuals aged 1-15 years old (including 15 years old).

Hepatitis A-susceptible individuals aged over 15 years old (excluding 15 years old).

For Adult Use：Hepatitis A-susceptible individuals aged over 15 years old (excluding 15 years old).

Strength

0.5ml per vial or syringe, 0.5ml per single human dose for children, containing 320EU of hepatitis A virus antigen.

1.0 ml per syringe, 1.0 ml per single human dose for adult, containing 640 EU of hepatitis A virus antigen.

Administration and Dosage

(1) Shake well before use. Inject single human dose im.at deltoid insertion area of the lateral upper arm.

(2) Eligibles of 1-15 years old (including 15 years old) should be administered the pediatric dose, A single dose of vaccine is used for primary immunization, and 1 dose of vaccine for booster immunization at 6 months interval. Each dose is 0.5 ml.

(3) Eligibles over 15 years old (excluding 15 years old) should be given the adult dose, with 1 dose of vaccine for initial immunization and 1 dose of vaccine for booster immunization at 6 months interval. Each dose is 1.0ml.

Storage and Packaging

Store and ship the product at 2-8℃, protected from light.

This product is packaged in a pre-filled syringe or vial, with 1 vial or syringe per small box.

The validity period is 36 months.

Why Choose Our Vaccine?

AIM Action hepatitis A inactivated vaccine, was listed on June 1, 2003, is one of the first inactivated vaccine enterprise to occupy the market in China.

After more than 20 years, AIM Action HAV has been tested and made a positive contribution to the elimination of viral hepatitis in China.